Cambridge-Based SAGE Therapeutics Readies $69 Million IPO Pitch To Develop CNS Drugs
Published: Jun 18, 2014
Sage Therapeutics made it pretty clear it was plotting an IPO when it added a group of public investment funds to its latest private financing round a few months ago. The Cambridge, MA-based company followed through today, filing papers outlining plans to tap Wall Street to develop drugs for rare neurological disorders.
Help employers find you! Check out all the jobs and post your resume.